BRIEF-Vermillion jumps after medical journal study on ovarian cancer test
NEW YORK Nov 28 (Reuters) - Vermillion Inc : * Jumps 45.4 percent to $1.73 after medical journal Gynecologic Oncology published clinical study results of the company's ovarian cancer test
- Exclusive: Secret contract tied NSA and security industry pioneer |
- U.S. aircraft hit by gunfire in South Sudan as conflict worsens
- With Fed out of the way, what's next on Wall Street?
- Four men arrested in deadly N.J. shopping mall carjacking
- Analysis: Lost Brazil order raises threat to Boeing fighter jets